National Athletic Trainers' Association position statement: Management of asthma in athletes

Journal of Athletic Training

Volumn 40, Issue 3, 2005, Pages 224-245

  Miller, Michael G ^a,f   Weiler, John M ^b   Baker, Robert ^c   Collins, James ^d   D'Alonzo, Gilbert ^e  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Michigan State University Kalamazoo Center for Medical Studies   (United States)

^d San Diego University   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f National Athletic Trainers' Association   (United States)

Author keywords

Airway hyperresponsiveness; Airway obstruction; Certified athletic trainer; Exercise induced asthma; Exercise induced bronchospasm; Pulmonary function tests

Indexed keywords

ACETYLSALICYLIC ACID; ARTHROTEC; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BUDESONIDE; CELECOXIB; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; ETODOLAC; FENOTEROL; FLURBIPROFEN; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; IBUPROFEN; INDOMETACIN; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; KETOPROFEN; KETOROLAC; LEVALBUTEROL; METHYLPREDNISOLONE; METHYLXANTHINE DERIVATIVE; MONTELUKAST; NABUMETONE; NAPROXEN; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PARACETAMOL; PIRBUTEROL; PIROXICAM; PREDNISOLONE; ROFECOXIB; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; SALSALATE; SULINDAC; TERBUTALINE SULFATE; THEOPHYLLINE; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

AIRWAY OBSTRUCTION; ANOREXIA; ASTHMA; ATHLETE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CAPILLARY RESISTANCE; COUGHING; DRUG MECHANISM; DYSPNEA; ELECTROLYTE DISTURBANCE; ENVIRONMENTAL FACTOR; EXERCISE; GASTROINTESTINAL DISEASE; GLAUCOMA; GLUCOSE INTOLERANCE; GROWTH INHIBITION; HEADACHE; HEALTH CARE QUALITY; HOARSENESS; HUMAN; HYPERTENSION; LIVER TOXICITY; LUNG FUNCTION TEST; OSTEOPOROSIS; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; SEIZURE; SIDE EFFECT; SKIN DISEASE; TACHYCARDIA; THRUSH; WEIGHT GAIN;

EID: 26644471734     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (305)

1. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. Publication No. 97-4051:12-18.
2. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2002. NIH publication No. 02-3659.
3. Nystad W. Asthma. Int J Sports Med. 2000;21(suppl):S-98-S-102.
4. Balatbat JH. Asthma: an overview from prevalence to plan. J Contin Educ Top Issues. 2002;2:80-92.
5. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33:208-213.
6. Tiddens H, Silverman M, Bush A. The role of inflammation in airway disease: remodeling. Am J Respir Crit Care Med. 2000;162(2, pt 2):S-7-S-10.
7. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720-1745.
8. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172:149-160.
9. Rupp NT, Guill NF, Brudno DS. Unrecognized exercise-induced bronchospasm in adolescent athletes. Am J Dis Child. 1992;146:941-944.
10. Rupp NT, Brudno DS, Guill MF. The value of screening for risk of exercise-induced asthma in high school athletes. Ann Allergy. 1993;70:339-342.
11. Hammerman St, Becker JM, Rogers J, Quedenfeld TC, D'Alonzo GE Jr. Asthma screening of high school athletes: identifying the undiagnosed and poorly controlled. Ann Allergy Asthma Immunol. 2002;88:380-384.
12. Hallstrand TS, Curtis JR, Koepsell TD, et al. Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr. 2002;141:343-348.
13. Weiler JM. Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment. Allergy Asthma Proc. 1996;17:315-325.
14. Lacroix VJ. Exercise-induced asthma. Physician Sportsmed. 1999;27(12):75-91.
15. Abu-Hasan M, Tannous B, Weinberger M. Exercise-induced dyspnea in children and adolescents; if not asthma then what? Ann Allergy Asthma Immunol. 2005;94:366-371.
16. West JB. Respiratory Physiology: The Essentials. Philadelphia, PA: Lippincott Williams & Wilkins: 2000.
17. Kanner RE, Morris AH, eds. Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures. Salt Lake City, UT: Intermountain Thoracic Society; 1975.
18. Petty TL. Simple office spirometry. Clin Chest Med. 2001;22:845-859.
19. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161:309-329.
20. Rundell KW, Wilber RL, Szmedra L, Jenkinson DM, Mayers LB, Im J. Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge. Med Sci Sports Exerc. 2000;32:309-316.
21. Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest. 2004;125:909-915.
22. Peak flow meters and spirometers in general practice. Drug Ther Bull. 1997;35:52-55.
23. Meadows-Oliver M, Banasiak NC. Asthma medication delivery devices. J Pediatr Health Care. 2005;19:121-123.
24. Im J. Asthma. RxConsultant. 2003;12:1-8.
25. Baker VO, Friedman J, Schmitt R. Asthma management, part II: pharmacologic management. J Sch Nurs. 2002;18:257-269.
26. Self TH, Kelly HW. Asthma. In: Young LY, Koda-Kimble MA, eds. Applied Therapeutics: The Clinical Use of Drugs. 6th ed. Vancouver, WA: Applied Therapeutics, Inc; 1995:19-1-19-31.
27. Drugs for asthma. Med Lett Drugs Ther. 1999;41:5-10.
28. Szilagyi PG, Kemper KJ. Management of chronic childhood asthma in the primary care office. Pediatr Ann. 1999;28:43-52.
29. Sherman J, Hendeles L. Practical pharmacology for pediatric asthma. Pediatr Ann. 2000;29:768-773.
30. Houglum JE. Asthma medications: basic pharmacology and use in the athlete. J Athl Train. 2000;35:179-187.
31. Hough DO, Dec KL. Exercise-induced asthma and anaphylaxis. Sports Med. 1994;18:162-172.
32. Gong H Jr. Breathing easy: exercise despite asthma. Physician Sportsmed. 1992;20(3):158-167.
33. McDonald E, Cook D, Newman T, Griffith L, Cox G, Guyatt G. Effect of air filtration systems on asthma: a systematic review of randomized trials. Chest. 2002;122:535-1542.
34. Reiff DB, Choudry NB, Pride NB, Ind PW. The effect of prolonged submaximal warm-up exercise on exercise-induced asthma. Am Rev Respir Dis. 1989;139:479-484.
35. Turner MO, Taylor D, Bennett R, Fitzgerald JM. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med. 1998;157:540-546.
36. Kolbe J, Vamos M, James F, Elkind G, Garrett J. Assessment of practical knowledge of self-management of acute asthma. Chest. 1996;109:86-90.
37. Lieu TA, Quesenberry CP Jr., Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics. 1997;100(3, pt 1):334-341.
38. Gibson PG, Wlodarczyk J, Hensley MJ, Murree-Allen K, Olson LG, Saltos N. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med. 1995;123:488-492.
39. Boggs PB, Hayati F, Washburne WF, Wheeler DA. Using statistical process control charts for the continual improvement of asthma care. Jt Comm J Qual Improv. 1999;25:163-181.
40. Allen RM, Jones MP, Oldenburg B. Randomised trial of an asthma self-management programme for adults. Thorax. 1995;50:731-738.
41. Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990;150:1664-1668.
42. Hilton S, Sibbald B, Anderson HR, Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet. 1986;1:26-29.
43. Yoon R, McKenzie DK, Bauman A, Miles DA. Controlled trial evaluation of an asthma education programme for adults. Thorax. 1993;48:1110-1116.
44. Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med. 1993;94:564-576.
45. Beilby JJ, Wakefield MA, Ruffin RE. Reported use of asthma management plans in South Australia. Med J Aust. 1997;166:298-301.
46. Dales RE, Kerr PE, Schweitzer I, Reesor K, Gougeon L, Dickinson G. Asthma management preceding an emergency department visit. Arch Intern Med. 1992;152:2041-2044.
47. Scarfone RJ, Zorc JJ, Capraro GA. Patient self-management of acute asthma: adherence to national guidelines a decade later. Pediatrics. 2001;108:1332-1338.
48. Adams RJ, Boath K, Homan S, Campbell DA, Ruffin RE. A randomized trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma. Respirology. 2001;6:297-304.
49. Myers TR. Improving patient outcomes with tools for asthma self-monitoring: a review of the literature. Dis Manag Health Outcomes. 2002;10:631-642.
50. Clark NM, Partridge MR. Strengthening asthma education to enhance disease control. Chest. 2002;121:1661-1669.
51. Lawrence G. Asthma self-management programs can reduce the need for hospital-based asthma care. Respir Care. 1995;40:39-43.
52. Partridge MR. Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education? Eur Respir J. 1995;8:298-305.
53. Bittleman DB, Smith RJH, Weiler JM. Abnormal movment of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete. Chest. 1994;106:615-616.
54. McFadden ER Jr, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma: a physiologic cause for "choking" during athletic activities. Am J Respir Crit Care Med. 1996;153:942-947.
55. Clark CJ, Cochrane LM. Physical activity and asthma. Curr Opin Pulm Med. 1999;5:68-75.
56. Guthrie CM, Tingen MS. Asthma: a case study, review of pathophysiology, and management strategies. J Am Acad Nurse Pract. 2002;14:457-461.
57. Wiggs BR, Bosken C, Paré PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:1251-1258.
58. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992;101:916-921.
59. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J. 1996;9:1395-1401.
60. Huber HL, Koessler KL. The pathology of bronchia! asthma. Arch Intern Med. 1922;30:689-760.
61. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27-33.
62. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: an alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis. 1989;139:450-457.
63. Persson CG. Role of plasma exudation in asthmatic airways. Lancet. 1986;2:1126-1129.
64. Djukanović R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis. 1990;142:863-871.
65. Koshino T, Arai Y, Miyamoto Y, et al. Mast cell and basophil number in the airway correlate with the bronchial responsiveness of asthmatics. Int Arch Allergy Immunol. 1995;107:378-379.
66. O'Byrne PM. Airway inflammation and asthma. Aliment Pharmacol Ther. 1996;10(supp1 2):18-24.
67. Hays SR, Fahy JV. The role of mucus in fatal asthma. Am J Med. 2003;115:68-69.
68. Kessler GF, Austin JH, Graf PD, Gamsu G, Gold WM. Airway constriction in experimental asthma in dogs: tantalum bronchographic studies. J Appl Physiol. 1973;35:703-708.
69. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993;147:405-410.
70. Awadh N, Müller NL, Park CS, Abboud RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax. 1998;53:248-253.
71. McFadden ER Jr. Development, structure, and physiology in the normal lung and in asthma. In: Middleton E, Ellis EF, Adkinson NF Jr, Yunginger JW, Reed CH, Busse WW, eds. Allergy Principles and Practice. St. Louis, MO: Mosby; 1998:508-519.
72. McFadden ER Jr, Kiser R, DeGroot WJ. Acute bronchial asthma: relations between clinical and physiologic manifestations. N Engl J Med. 1973;288:221-225.
73. National Center for Health Statistics. NCHS Data on Asthma. Available at: http://www.cdc.gov/nchs/data/factsheets/asthma.pdf. Accessed June 6, 2005.
74. D'Amato G, Liccardi G, Cazzola M. Environment and development of respiratory allergy, I: outdoors. Monaldi Arch Chest Dis. 1994;49:406-411.
75. D'Amato G, Liccardi G, D'Amato M. Environment and development of respiratory allergy, II: indoors. Monaldi Arch Chest Dis. 1994;49:412-420.
76. Steerenberg PA, Van Amsterdam JGC, Vandebriel BJ, Vos JG, Van Bree L, Van Loveren H. Environmental and lifestyle factors may act in concert to increase the prevalence of respiratory allergy including asthma. Clin Exp Allergy. 1999;29:1303-1308.
77. Sunyer J, Antò JM, Kogevinas M, et al. Risk factors for asthma in young adults: Spanish Group of the European Community Respiratory Health Survey. Eur Respir J. 1997;10:2490-2494.
78. Grant EN, Wagner R, Weiss KB. Observations on emerging patterns of asthma in our society. J Allergy Clin Immunol. 1999;104(2, pt 2):S-1-S-9.
79. Koenig JQ. Air pollution and asthma. J Allergy Clin Immunol. 1999;104(4, pt 1):717-722.
80. Custovic A, Simpson A, Woodcock A. Importance of indoor allergens in the induction of allergy and elicitation of allergic disease. Allergy. 1998;53(48 suppl):115-20.
81. Jones AP. Asthma and the home environment. J Asthma. 2000;37:103-124.
82. Platts-Mills TAE. Allergen avoidance. J Allergy Clin Immunol. 2004;113:388-391.
83. Platts-Mills TAE, Ward GW Jr, Sporik R, Gelber LE, Chapman MD, Heymann PW. Epidemiology of the relationship between exposure to indoor allergens and asthma. Int Arch Allergy Appl Immunol. 1991;94:339-345.
84. Gruchalla RS, Pongracic J, Plaut M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol. 2005;115:478-485.
85. Platts-Mills TAE, Vervloet D, Thomas WR, Aalberse RC, Chapman MD. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol. 1997;100:S-1-S-24.
86. Hirsch T, Hering M, Bürkner K, et al. House-dust-mite allergen concentrations (Der f 1) and mold spores in apartment bedrooms before and after installation of insulated windows and central heating systems. Allergy. 2000;55:79-83.
87. Schoenwetter WF. Building a healthy house. Ann Allergy Asthma Immunol. 1997;79:1-4.
88. Woodfolk JA, Luczynska CH, de Blay F, Chapman MD, Platts-Mills TAE. Cat allergy. Ann Allergy. 1992;69:273-275.
89. Sarpong SB, Karrison T. Season of birth and cockroach allergen sensitization in children with asthma. J Allergy Clin Immunol. 1998;101(4, pt 1):566-568.
90. Kuster PA. Reducing risk of house dust mite and cockroach allergen exposure in inner-city children with asthma. Pediatr Nurs. 1996;22:297-303.
91. Kang BC, Wu CW, Johnson J. Characteristics and diagnosis of cockroach-sensitive bronchial asthma. Ann Allergy. 1992;68:237-244.
92. Liccardi G, Cazzola M, D'Amato M, D'Amato G. Pets and cockroaches: two increasing causes of respiratory allergy in indoor environments. Characteristics of airways sensitization and prevention strategies. Respir Med. 2000;94:1109-1118.
93. Platt SD, Martin CJ, Hunt SM, Lewis CW. Damp housing, mould growth, and symptomatic health state. BMJ. 1989;298:1673-1678.
94. Potter PC, Juritz J, Little F, McCaldin M, Dowdle EB. Clustering of fungal allergen-specific IgE antibody responses in allergic subjects. Ann Allergy. 1991;66:149-153.
95. Henderson FW, Henry MM, Ivins SS, et al. Correlates of recurrent wheezing in school-age children: The Physicians of Raleigh Pediatric Associates. Am J Respir Crit Care Med. 1995;151:1786-1793.
96. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol. 1992;90(4, pt 1):579-588.
97. Duffy DL, Mitchell CA, Martin NG. Genetic and environmental risk factors for asthma: a cotwin-control study. Am J Respir Crit Care Med. 1998;157(3, pt 1):840-845.
98. 1 in adults of a Norwegian community. Am J Respir Crit Care Med. 1995;152(4, pt 1):1158-1163.
99. Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community. Eur Respir J. 1996;9:919-925.
100. Turner KJ, Stewart GA, Woolcock AJ, Green W, Alpers MP. Relationship between mite densities and the prevalence of asthma: comparative studies in two populations in the Eastern Highlands of Papua New Guinea. Clin Allergy. 1988;18:331-340.
101. Vervloet D, Charpin D, Haddi E, et al. Medication requirements and house dust mite exposure in mite-sensitive asthmatics. Allergy. 1991;46:554-558.
102. Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol. 1998;101:587-593.
103. Call RS, Smith TF, Morris E, Chapman MD, Platts-Mills TAE. Risk factors for asthma in inner city children. J Pediatr. 1992;121:862-866.
104. Platts-Mills TAE, Woodfolk JA, Chapman MD, Heymann PW. Changing concepts of allergic disease: the attempt to keep up with real changes in lifestyles. J Allergy Clin Immunol. 1996;98(6, pt 3):S-297-S-306.
105. Forastiére F, Corbo GM, Michelozzi P, et al. Effects of environment and passive smoking on the respiratory health in children. Int J Epidemiol. 1992;21:66-73.
106. Gortmaker SL, Walker DK, Jacobs FH, Ruch-Ross H. Parental smoking and the risk of childhood asthma. Am J Public Health. 1982;72:574-579.
107. Koenig JQ, Larson TV, Hanley QS, et al. Pulmonary function changes in children associated with fine particulate matter. Environ Res. 1993;63:26-38.
108. Murray B, Morrison BJ. The effect of cigarette smoke from the mother on bronchial responsiveness and severity of symptoms in children with asthma. J Allergy Clin Immunol. 1986;77:575-581.
109. Halken S, Host A, Nilsson L, Taudorf E. Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization. Allergy. 1995;50:97-105.
110. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study: Epidemiological Study on the Genetics and Environment of Asthma. Eur Respir J. 2000;15:470-477.
111. Bar-Or O, Inbar O. Swimming and asthma: benefits and deleterious effects. Sports Med. 1992;14:397-405.
112. Massin N, Bohadana AB, Wild P, Hery M, Toamain JP, Hubert G. Respiratory symptoms and bronchial responsiveness in lifeguards exposed to nitrogen trichloride in indoor swimming pools. Occup Environ Med. 1998;55:258-263.
113. Bernard A, Carbonnelle S, Michel O, et al. Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med. 2003;60:385-394.
114. Thickett KM, McCoach JS, Gerber JM, Sadhra S, Burge PS. Occupational asthma caused by chloramines in indoor swimming-pool air. Eur Respir J. 2002;19:827-832.
115. Nemery B, Hoet PHM, Nowak D. Indoor swimming pools, water chlorination and respiratory health. Eur Respir J. 2002;19:790-793.
116. Zwemer RJ, Karibo J. Use of laminar control device as adjunct to standard environmental control measures in symptomatic asthmatic children. Ann Allergy. 1973;31:284-290.
117. Villaveces JW, Rosengren H, Evans J. Use of a laminar air flow portable filter in asthmatic children. Ann Allergy. 1977;38:400-404.
118. Kooistra JB, Pasch R, Reed CE. The effects of air cleaners on hay fever symptoms in air-conditioned homes. J Allergy Clin Immunol. 1978;61:315-319.
119. Wood RA, Mudd KE, Egglestone PA. The distribution of cat and dust mite allergens on wall surfaces. J Allergy Clin Immunol. 1992:89(1, pt 1):126-130.
120. Shirai T, Matsui T, Suzuki K, Chida K. Effect of pet removal on pet allergic asthma. Chest. 2005;127:1565-1571.
121. Folinsbee LJ. Does nitrogen dioxide exposure increase airways responsiveness? Toxicol Ind Health. 1992;8:273-283.
122. 10 pollution: a daily time series analysis. Am Rev Respir Dis. 1991;144(3, pt 1):668-674.
123. Delfino RJ, Coate BD, Zeiger RS, Seltzer JM, Street DH, Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med. 1996;154(3, pt 1):633-641.
124. Delfino RJ, Zeiger RS, Seltzer JM, Street DH. Symptoms in pediatric asthmatics and air pollution: differences in effects by symptoms severity, anti-inflammatory medication use and particulate averaging time. Environ Health Perspect. 1998;106:751-761.
125. 2 plus NaCl aerosol combined with moderate exercise on pulmonary function in asthmatic adolescents. Environ Res. 1981;25:340-348.
126. Suphioglu C, Singh MB, Taylor P, et al. Mechanism of grass-pollen-induced asthma. Lancet. 1992;339:569-572.
127. Helenius I, Haahtela T. Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol. 2000;106:444-452.
128. Solomon WR. Airborne pollen prevalence in the United States. In: Grammer LC, Greenberger PA, eds. Patterson's Allergic Diseases. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:131-144.
129. D'Amato G, Spieksma FT, Liccardi G, et al. Pollen-related allergy in Europe. Allergy. 1998;53:567-578.
130. Rundell KW, Spiering BA, Evans TM, Baumann JM. Baseline lung function, exercise-induced bronchoconstriction, and asthma-like symptoms in elite women ice hockey players. Med Sci Sports Exerc. 2004;36:405-410.
131. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202-1218.
132. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care. 2000;45:513-530.
133. Guidelines for the measurement of respiratory function: recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med. 1994;88:165-194.
134. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123:659-664.
135. Polgar G, Promadhat V. Pulmonary Function Testing in Children. Philadelphia, PA: WB Saunders; 1971.
136. Standardization of spirometry: 1994 update. American Thoracic Society. Am Respir Crit Care Med. 1995;152:1107-1136.
137. Koyama H, Nishimura K, Ikeda A, Tsukino M, Izumi T. Comparison of four types of portable peak flow meters (Mini-Wright, Assess, Pulmograph and Wright Pocket meters). Respir Med. 1998;92:505-511.
138. 1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax. 1988;43:335-336.
139. Ladebauche P. Peak flow meters: child's play. Office Nurse. 1996:22-28.
140. Li JTC. Do peak flow meters lead to better asthma control? J Respir Dis. 1995;16:381-398.
141. Ignacio-Garcia JM, Gonzales-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med. 1995;151:353-359.
142. Measuring peak flow at home. Drug Ther Bull. 1991;29:87-88.
143. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ. 1998;316:1138-1139.
144. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ. 1996;312:748-752.
145. Wagner MH, Jacobs J. Improving asthma management with peak flow meters. Contemp Pediatr. 1997;14:111-119.
146. Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom self monitoring of asthma initiated from community pharmacies. J Clin Pharm Ther. 2001;26:287-296.
147. Cowie RL, Revitt SG, Underwood MF, Field SK. The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest. 1997;112:1534-1538.
148. Rachelefsky G, Fitzgerald S, Page D, Santamaria B. An update on the diagnosis and management of pediatric asthma: based on the National Heart, Lung, and Blood Institute expert panel report. Nurse Pract. 1993;18:51-62.
149. Killian KJ, Watson R, Otis J, St Amand TA, O'Bryne PM. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med. 2000;162(2, pt 1):490-496.
150. Kendrick AH, Higgs CMB, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993;307:422-424.
151. Klements EM. Monitoring peak flow rates as a health-promoting behavior in managing and improving asthma. Clin Excell Nurse Pract. 2001;5:147-151.
152. Malo JL, L'Archevêque J, Trudeau C, d'Aquino C, Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J Allergy Clin Immunol. 1993;91:702-709.
153. Verschelden P, Cartier A, L'Archevêque J, Trudeau C, Malo JL. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J. 1996;9:880-885.
154. Sawyer G, Miles J, Lewis S, Fitzharris P, Pearce N, Beasley R. Classification of asthma severity: should the international guidelines be changed? Clin Exp Allergy. 1998;28:1565-1570.
155. Eid N, Yandell B, Howell L, Eddy M, Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics. 2000;105:354-358.
156. Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroids: Dutch CNSLD Study. Thorax. 1999;54:103-107.
157. Folgering H, vd Brink W, v Heeswijk O, v Herwaarden C. Eleven peak flow meters: a clinical evaluation. Eur Respir J. 1998;11:188-193.
158. Jain P, Kavuru MS. Peak expiratory flow vs spirometry in a patient with asthma. Respir Care. 2000;45:969-970.
159. Nolan S, Tolley E, Leeper K, Strayhorn Smith V, Self T. Peak expiratory flow associated with change in positioning of the instrument: comparison of five peak flow meters. J Asthma. 1999;36:291-294.
160. Connolly CK, Murthy NK, Tighe E, Alcock S, Harding T. Mini and Wright peak flow meters. Thorax. 1991;46:289P.
161. Dickinson SA, Hitchins DJ, Miller MR. Accuracy of measurement of peak flow using different peak flow meters. Thorax. 1991;46:289P.
162. Jain P, Kavuru MS. Peak expiratory flow vs spirometry in a patient with asthma. Respir Care. 2000;45:969-970.
163. Gardner RM, Crapo RO, Jackson BR, Jensen RL. Evaluation of accuracy and reproducibility of peak flow meters at 1,400 m. Chest. 1992;101:948-952.
164. Chafin CC, Tolley E, George C, et al. Are there gender differences in the use of peak flow meters? J Asthma. 2001;38:541-543.
165. den Otter JJ, Knitel M, Akkermans RPM, Van Schayck CP, Folgering HTM, van Weel C. Spirometry in general practice: the performance of practice assistants scored by lung function technicians. Br J Gen Pract. 1997;47;41-42.
166. Flood-Page P, Barnes NC. What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma? BioDrugs. 2001;15:185-198.
167. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol. 1986;77(1, pt 1):65-70.
168. Jeffery PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis. 1992;145(4, pt 1):890-899.
169. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992;145:669-674.
170. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992;90:32-42.
171. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness, and symptoms in children with asthma: the Dutch Chronic Non-Specific Lung Disease Study Group. Am Rev Respir Dis. 1992;146:547-554.
172. Munck A, Mendel DB, Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Respir Dis. 1990;141(2, pt 2):S-2-S-10.
173. Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 1990;141(2, pt 2):S-59-S-69.
174. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SL. NIH conference: airway inflammation. Ann Intern Med. 1995;123:288-304.
175. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388-392.
176. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3, pt2):S-1-S-53.
177. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma: report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis. 1993;148(4, pt 2):S-1-S-26.
178. Long-term effects of budesonide or nedocromil in children with asthma: The Childhood Asthma Management Program Research Group. N Engl J Med. 2000;343:1054-1063.
179. Greenberger PA, Tatum AJ, D'Epiro P. Asthma: acute and long-term concerns. Patient Care. 1999;15:154-174.
180. Bleecker ER, Welch MJ, Weinstein SF, et al. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. J Allergy Clin Immunol. 2000;105:1123-1129.
181. Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J. 1995;8:590-592.
182. Mash B, Bheekie A, Jones PW. Inhaled versus oral steroids for adults with chronic asthma (Cochrane Review). In: The Cochrane Library. Issue 4. Chichester, UK: John Wiley and Sons, Ltd: 2003.
183. Dunlap NE, Fulmer JD. Corticosteroid therapy in asthma. Clin Chest Med. 1984;5:669-683.
184. Serafin WE. Drugs used in the treatment of asthma. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:659-682.
185. Nelson HS. β-adrenergic bronchodilators. N Engl J Med. 1995;333:499-506.
186. Boulet LP. Long versus short-acting beta 2-agonists: implications for drug therapy. Drugs. 1994;47:207-222.
187. Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med. 1992;327:1420-1425.
188. Kesten S, Chapman KR, Broder I, et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis. 1991;144:622-625.
189. 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Paediatr Drugs. 2004;6:161-175.
190. Wenzel SE, Lumry W, Manning M, et al. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma. Ann Allergy Asthma Immunol. 1998;80:463-470.
191. Selroos O. Formoterol used as needed: clinical effectiveness. Respir Med. 2001;95:17-20.
192. Richter K, Jamicki S, Jorres RA, Magnussen H. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol, and terbutaline. Eur Respir J. 2002;19(suppl B):865-871.
193. Bronsky EA, Yegen U, Yeh CM, Larsen LV, Della Cioppa G. Formoterol provides long-lasting protection against exercise-induced bronchospasm. Ann Allergy Asthma Immunol. 2002;89:417-412.
194. Ferrari M, Segattini C, Zanon R, et al. Comparison of the protective effect of formoterol and of salmerterol against exercise-induced bronchospasm when given immediately before a cycloergometric test. Respiration. 2002;69:509-512.
195. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002;165:1068-1070.
196. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmerterol. Respir Med. 1994;88:363-368.
197. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER Jr. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998;339:141-146.
198. Garcia R, Guerra P, Feo F, et al. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. J Investig Allergol Clin Immunol. 2001;11:176-182.
199. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med. I994;150:1006-1011.
200. Lemanske RF, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA. 2001;285:2594-2603.
201. 2- agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285:2583-2593.
202. Weiler JM, Nathan RA, Rupp NT, Kalberg CJ, Emmett A, Dorinsky PM. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol. 2005;94:65-72.
203. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MI-ASMA). BMJ. 2000;320:1368-1373.
204. Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337:1405-1411.
205. Holimon TD, Chafin CC, Self TH. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists? Drugs. 2001;61:391-418.
206. Montelukast for persistent asthma. Med Lett Drugs Ther. 1998;40:71-73.
207. Stempel DA. Leukotriene modifiers in the treatment of asthma. Respir Care. 1998;43:481-489.
208. O'Byrne PM, Israel E, Drazen JM. Antileukotreines in the treatment of asthma. Ann Intern Med. 1997;127:472-480.
209. Lipworth BJ. Leukotriene-receptor antagonists. Lancet. 1999;353:57-62.
210. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340:197-206.
211. Drazen JM. Asthma therapy with agents preventing leukotriene synthesis or action. Proc Assoc Am Physicians. 1999;111:547-559.
212. Dahlén B, Margolskee DJ, Zetterström O, Dahlén S. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax. 1993;48:1205-1210.
213. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Thorax. 2000;55:478-483.
214. Christian Virchow J, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162:578-585.
215. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 1998;339:147-152.
216. Laviolette M, Malmstrom K, Lu S, et al. Montelukast added to inhaled beclomethasone in treatment of asthma: Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med. 1999;160:1862-1868.
217. Lofdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319:87-90.
218. Joshi EM, Heasley BH, Chordia MD, Macdonald TL. In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity. Chem Res Toxicol. 2004;17:137-143.
219. Ukena D, Harnest U, Sakalauskas R, et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J. 1997;10:2754-2760.
220. Norman PS. Tmmunotherapy: 1999-2004. J Allergy Clin Immunol. 2004;113:1013-1023.
221. Stokes J, Casale TB. Rationale for new treatments aimed at IgE immunomodulation. Ann Allergy Asthma Immunol. 2004;93:212-217.
222. Creticos PS, Chen YH, Schroeder JT. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. Immunol Allergy Clin North Am. 2004;24:569-581.
223. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med. 1993;87:331-344.
224. Holzer K, Brukner P, Douglass J. Evidence-based management of exercise-induced asthma. Curr Sports Med Rep. 2002;1:86-92.
225. Sears MR, Lotvall J. Past, present and future-beta2-adrenoceptor agonists in asthma management. Respir Med. 2005;99:152-170.
226. Knöpfli BH. Bar-Or O, Araúgo CG. Effect of ipratropium bromide on EIB in children depends on vagal activity. Med Sci Sports Exerc. 2005;37:354-359.
227. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med. 1996;334:1380-1388.
228. Sessler CN. Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med. 1990;88:567-576.
229. Dozor AJ. Spacer crusader. Lancet. 2005;365:572.
230. Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet. 2004;43:349-60.
231. Newman KB, Milne S, Hamilton C, Hall K. A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. Chest. 2002;121:1036-1041.
232. Stevenson DD. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am. 2004;24:491-505.
233. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2002;89:542-550.
234. Jawien J. A new insight into aspirin-induced asthma. Eur J Clin Invest. 2002;32:134-138.
235. de Almeida MA, Caspar AP, Carvalho FS, Nogueira JM, Pinto JE. Adverse reactions to acetaminophen, ASA, and NSAIDs in children: what alternatives? Allergy Asthma Proc. 1997;18:313-318.
236. Vaszar LT, Stevenson DD. Aspirin-induced asthma. Clin Rev Allergy Immunol. 2001;21:71-87.
237. Rivas B. The management of ASA syndrome. J Invest Allergol Clin Immunol. 1997;7:392-396.
238. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999;28:717-722.
239. Levy S, Volans G. The use of analgesics in patients with asthma. Drug Safe. 2001;24:829-841.
240. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104:5-13.
241. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol. 1989;84:26-33.
242. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-921.
243. Mellion MB, Kobayashi RH. Exercise-induced asthma. Am Fam Physician. 1992;45:2671-2677.
244. Rupp NT. Diagnosis and management of exercise-induced asthma. Physician Sportsmed. 1996;24(1):77-87.
245. Baker WH, Weiler JM. The role of exercise training and conditioning in patients with asthma. In: Weiler JM, ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY: Marcel Dekker; 1997:179-206.
246. Cochrane LM, Clark CJ. Benefits and problems of a physical training programme for asthmatic patients. Thorax. 1990;45:345-351.
247. Ben Dov I, Bar-Yishay E, Godfrey S. Refractory period after exercise-induced asthma unexplained by respiratory heat loss. Am Rev Respir Dis. 1982;125:530-534.
248. Belcher NG, O'Hickey S, Arm JP, Lee TH. Pathogenetic mechanisms of exercise-induced asthma and the refractory period. N Engl Reg Allergy Proc. 1988;9:199-201.
249. McKenzie DC, McLuckie SL, Stirling DR. The protective effects of continuous and interval exercise in athletes with exercise-induced asthma. Med Sci Sports Exerc. 1994;26:951-956.
250. Morton AR, Fitch KD, Davis T. The effect of "warm-up" on exercise-induced asthma. Ann Allergy. 1979;42:257-260.
251. Schnall RP, Landau LI. Protective effects of repeated short sprints in exercise-induced asthma. Thorax. 1980;35:828-832.
252. Mickleborough TD, Gotshall RW, Cordain L, Lindley M. Dietary salt alters pulmonary function during exercise in exercise-induced asthmatics. J Sports Sci. 2001;19:865-873.
253. Gotshall RW, Mickleborough TD, Cordain L. Dietary salt restriction improves pulmonary function in exercise-induced asthma. Med Sci Sports Exerc. 2000;32:1815-1819.
254. Mickleborough TD, Gotshall RW, Kluka EW, Miller CW, Cordian L. Dietary chloride as a possible determinant of the severity of exercise-induced asthma. Eur J Appl Physiol. 2001;85:450-456.
255. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003;168:1181-1189.
256. Weiler JM, ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY: Marcel Dekker: 1997.
257. McFadden ER Jr, ed. Exercise-Induced Asthma. New York, NY: Marcel Dekker: 1999.
258. Homnick DN, Marks JH. Exercise and sports in the adolescent with chronic pulmonary disease. Adolesc Med. 1998;9:467-481.
259. Milgrom H, Taussig LM. Keeping children with exercise-induced asthma active. Pediatrics. 1999;104:38-42.
260. Langdeau JB, Boulet LP. Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes. Sports Med. 2001;31:601-616.
261. Sudhir P, Prasad CE. Prevalence of exercise-induced bronchospasm in schoolchildren: an urban-rural comparison. J Trop Pediatr. 2003;49:104-108.
262. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol. 1998;102:722-726.
263. Weiler JM, Ryan EJ III. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol. 2000;106:267-271.
264. Storms WW. Review of exercise-induced asthma. Med Sci Sports Exerc. 2003;35:1464-1470.
265. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc. 2000;32:732-737.
266. Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med. 2002;32:583-600.
267. Feinstein RA, LaRussa J, Wang-Dohlman A, Bartolucci AA. Screening adolescent athletes for exercise-induced asthma. Clin J Sport Med. 1996;6:119-123.
268. Tan RA, Spector SL. Exercise-induced asthma. Sports Med. 1998;25:1-6.
269. Spector SL. Update on exercise-induced asthma. Ann Allergy. 1993;71:571-577.
270. Bierman EW, Kawabori I, Pierson WE. Incidence of exercise-induced asthma in children. Pediatrics. 1975;56(5, pt 2 suppl.):847-850.
271. Kovan JR, Mackowiak TJ. Exercise-induced asthma. Athl Ther Today. 2001;6(5):22-25, 34-35, 64.
272. McConnell R, Berhane K, Gilliland F, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet. 2002;359:386-391.
273. Peter MM, Silvers WS, Thompson FL, Weiler JM. Case studies of asthma in elite and world-class athletes: the roles of the athletic trainer and physician. In: Weiler JM, ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY: Marcel Dekker; 1997:353-375.
274. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086-91.
275. Larsson K, Ohlsén P, Larsson L, Malmberg P, Rydström P-O, Ulriksen H. High prevalence of asthma in cross country skiers. BMJ. 1993;307:1326-1329.
276. Anderson SD, Daviskas E. Pathophysiology of exercise-induced asthma: the role of respiratory water loss. In: Weiler JM. ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY: Marcel Dekker; 1997:87-114.
277. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes? J Allergy Clin Immunol. 2000;106:419-428.
278. McFadden ER Jr, Nelson JA, Skowronski ME, Lenner KA. Thermally induced asthma and airway drying. Am J Respir Crit Care Med. 1999;160:221-226.
279. Makker HK, Holgate ST. Pathophysiology: role of mediators in exercise-induced asthma. In: Weiler JM, ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY: Marcel Dekker; 1997:115-136.
280. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is... J Allergy Clin Immunol. 2000;106:453-459.
281. Deal EC Jr., McFadden ER Jr, Ingram RH Jr. Strauss RH, Jaeger JJ. Role of respiratory heat exchange in production of exercise-induced asthma. J Appl Physiol. 1979;46:467-475.
282. Chen WY, Horton DJ. Heat and water loss from the airways and exercise-induced asthma. Respiration. 1977;34:305-313.
283. Gilbert IA, McFadden ER Jr. Airway cooling and rewarming: the second reaction sequence in exercise-induced asthma. J Clin Invest. 1992;90:699-704.
284. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep. 2005;5:116-122.
285. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma: new insights into pathophysiology and possible pathogenesis. J Clin Invest. 1986;78:18-25.
286. Smith CM, Anderson SD, Walsh S, McElrea MS. An investigation of the effects of heat and water exchange in the recovery period after exercise in children with asthma. Am Rev Respir Dis. 1989;140:598-605.
287. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. 1994;330:1362-1367.
288. Beck KC. Control of airway function during and after exercise in asthmatics. Med Sd Sports Exerc. 1999;31:S-4-S-11.
289. Makker HK, Holgate ST. Mechanisms of exercise-induced asthma. Eur J Clin Invest. 1994;24:571-585.
290. Furuichi S, Hashimoto S, Gon Y, Matsumoto K, Horie T. p38 mitogen-activated protein kinase and C-Jun-NH2 terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells. Respirology. 2002;7:193-200.
291. Rundell KW. Pulmonary function decay in women ice hockey players: is there a relationship to ice rink air quality? Inhal Toxicol. 2004;16:117-123.
292. Zainudin NM, Aziz BA, Haifa AL, Deng CT, Omar AH. Exercise-induced bronchoconstriction among Malay schoolchildren. Respirology. 2001;6:151-155.
293. Jones A, Bowen M. Screening for childhood asthma using an exercise test. Br J Gen Pract. 1994;44:127-131.
294. Vianne EO, Boaventura LC, Terra-Filho J, Nakama GY, Martinez JAB, Martinez RJ. Morning-to-evening variation in exercise-induced bronchospasm. J Allergy Clin Immunol. 2002;110:236-240.
295. Anderson SD. Exercise-induced asthma and the use of hypertonic saline aerosol as a bronchial challenge. Respirology. 1996;3:175-181.
296. Tilles SA. Vocal cord dysfunction in children and adolescents. Curr Allergy Asthma Rep. 2003;3:467-472.
297. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest. 2003;123:468-474.
298. Wilkerson LA. Exercise-induced asthma. J Am Osteopath Assoc. 1998;98:211-215.
299. Smith BW, LaBotz M. Pharmacologic treatment of exercise-induced asthma. Clin Sports Med. 1998;17:343-363.
300. Fowler C. Preventing and managing exercise-induced asthma. Nurse Pract. 2001;26:25-33.
301. Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1612-1615.
302. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991;143:1317-1321.
303. Nastasi KJ, Heinly TL, Blaiss MS. Exercise-induced asthma and the athlete. J Asthma. 1995;32:249-257.
304. Finch L. Asthma education is key. J Respir Care Pract. 2000;85-116.
305. Dawson KP, Van Asperen P, Higgins C, Sharpe C, Davis A. An evaluation of the action plans of children with asthma. J Paediatr Child Health. 1995;31:21-23.